Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Dystonia, Elevated brain choline level by MRS, Muscle stiffness (rigidity), and Elevated brain lactate level by MRS and others; and common findings: Ataxia. 23 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 12 | Dystonia, Seizure, Elevated brain choline level by MRS |
NDUFAF6 encodes NADH:ubiquinone oxidoreductase complex assembly factor 6 (333 aa). Involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I) at early stages. May play a role in the biogenesis of complex I subunit MT-ND1 Highest expression in Brain Cerebellar Hemisphere (7.9 TPM) and Thyroid (7.7 TPM).
Mitochondrial complex I deficiency, nuclear type 17 is associated with mutations in the NDUFAF6 gene on chromosome 8.
NDUFAF6 is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for NDUFAF6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for mitochondrial complex I deficiency, nuclear type 17 has been reported in the published literature.
Phenotype severity distribution: 17 always present features, 1 common feature.
No clinical trials have been registered for mitochondrial complex I deficiency, nuclear type 17.
6 publications have been identified in PubMed for mitochondrial complex I deficiency, nuclear type 17. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (33%), and Diagnostic / Biomarker (17%).
Jiang F (2026). [PMID: 41399147](https://pubmed.ncbi.nlm.nih.gov/41399147/). *Journal of clinical laboratory analysis*. [Basic Science / Preclinical]
Yang Q (2026). [PMID: 41982415](https://pubmed.ncbi.nlm.nih.gov/41982415/). *Front Neurol*. [Case Report / Case Series]
de la Calle Arregui C (2025). [PMID: 41427350](https://pubmed.ncbi.nlm.nih.gov/41427350/). *bioRxiv : the preprint server for biology*. [Basic Science / Preclinical]
Hock DH (2025). [PMID: 40400026](https://pubmed.ncbi.nlm.nih.gov/40400026/). *Genome medicine*. [Diagnostic / Biomarker]
Zhou Y (2024). [PMID: 39720739](https://pubmed.ncbi.nlm.nih.gov/39720739/). *Molecular genetics and metabolism reports*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 7:49 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Muscles |
3 |
Low muscle tone (hypotonia), Muscle weakness, Skeletal muscle atrophy |
Bones and joints | 2 | Skeletal muscle atrophy, Sideways curvature of the spine (scoliosis) |
Lab test results | 2 | Increased circulating lactate concentration, Decreased activity of mitochondrial complex I |
Head and neck | 1 | High, narrow palate |
Rouzier C (2024). [PMID: 38703036](https://pubmed.ncbi.nlm.nih.gov/38703036/). *Annals of clinical and translational neurology*. [Epidemiology / Natural History]